[1]
|
Midgard, R., Riise, T. and Nyland, H. (1991) Epidemiologic Trends in Multiple Sclerosis in More and Romsdal, Norway: A Prevalence/Incidence Study in a Stable Population. Neurology, 41, 887-892. https://doi.org/10.1212/WNL.41.6.887
|
[2]
|
Gronning, M., Riise, T., Kvale, G., Nyland, H., Larsen, J.L. and Aarli, J.A. (1991) Incidence of Multiple Sclerosis in Hordaland, Western Norway: A Fluctuating Pattern. Neuroepidemiology, 10, 53-61. https://doi.org/10.1159/000110247
|
[3]
|
Larsen, J.L., Aarli, J.A., Nyland, H. and Riise, T. (1984) Western Norway, a High-Risk Area for Multiple Sclerosis: A Prevalence/Incidence Study in the County of Hordaland. Neurology, 34, 1202-1207. https://doi.org/10.1212/WNL.34.9.1202
|
[4]
|
Gronning, M. and Mellgren, S.I. (1985) Multiple Sclerosis in the Two Most Northern Counties of Norway. Acta Neurologica Scandinavica, 72, 321-327.
https://doi.org/10.1111/j.1600-0404.1985.tb00878.x
|
[5]
|
Grytten, N., Glad, S.B., Aarseth, J.H., Nyland, H., Midgard, R. and Myhr, K.-M. (2006) A 50-Year Follow-Up of the Incidence of Multiple Sclerosis in Hordaland County, Norway. Neurology, 66, 182-186.
https://doi.org/10.1212/01.wnl.0000195549.95448.b9
|
[6]
|
Elian, M., Nightingale, S. and Dean, G. (1990) Multiple Sclerosis among United Kingdom-Born Children of Immigrants from Indian Subcontinent, Africa and the West Indies. Journal of Neurology, Neurosurgery & Psychiatry, 53, 906-911.
https://doi.org/10.1136/jnnp.53.10.906
|
[7]
|
Kurtzke, J.F. (1991) Multiple Sclerosis: Changing Times. Neuroepidemiology, 10, 1-8. https://doi.org/10.1159/000110240
|
[8]
|
Granieri, E., Casetta, I. and Tola, M.R. (1995) Epidemiology of Multiple Sclerosis in Italy and Southern Europe. Acta Neurologica Scandinavica, S161, 60-70.
https://doi.org/10.1111/j.1600-0404.1995.tb05859.x
|
[9]
|
Poskanzer, D.C., Prenney, L.B., Sheridan, J.L. and Kondy, J.Y. (1980) Multiple Sclerosis in the Orkney and Shetland Islands. 1. Epidemiology, Clinical Factors, and Methodology. Journal of Epidemiology and Community Health, 34, 229-239.
https://doi.org/10.1136/jech.34.4.229
|
[10]
|
Lauer, K. and Firnaber, W. (1992) Epidemiologic Aspects of Multiple Sclerosis. Versicherungsmedizin, 44, 125-130.
|
[11]
|
Ebers, G.C. and Sadovnick, A.D. (1993) The Geographic Distribution of Multiple Sclerosis: A Review. Neuroepidemiology, 12, 1-5.
https://doi.org/10.1159/000110293
|
[12]
|
Bobowick, A.R., Kurtzke, J.F., Brody, J.A., Hrubec, Z. and Gillespie, M. (1978) Twin study of Multiple Sclerosis: An Epidemiologic Inquiry. Neurology, 28, 878-987.
https://doi.org/10.1212/WNL.28.10.978
|
[13]
|
Kinnunen, E., Koskenvus, M., Vario, J. and Ano, K. (1987) Multiple Sclerosis in a Nationwide Series of Twins. Neurology, 37, 1627-1629.
https://doi.org/10.1212/WNL.37.10.1627
|
[14]
|
Heltberg, A. (1987) Twin Studies in Multiple Sclerosis. The Italian Journal of Neurological Sciences, Suppl. 6, 35-39.
|
[15]
|
James, W.H. (1985) Sib Risk and the Dizygotic Twin Concordance Rate for Multiple Sclerosis. Journal of Epidemiology & Community Health, 39, 39-43.
https://doi.org/10.1136/jech.39.1.39
|
[16]
|
Matthews, W.B. (1991) McAlpine’s Multiple Sclerosis. 2nd Edition, Edinburgh Churchill Livingstone.
|
[17]
|
Kermode, A.G., Tofts, P.S., Thompson, A.J., et al. (1990) Heterogeneity of Blood-Brain Barrier Changes in Multiple Sclerosis: An MRI Study. Neurology, 40, 229-235.
https://doi.org/10.1212/WNL.40.2.229
|
[18]
|
Fletcher, J.M., Lalor, S.J., Sweeney, C.M., Tubridy, N. and Mills, K.H.G. (2010) T Cells in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis. Clinical & Experimental Immunology, 162, 1-11.
https://doi.org/10.1111/j.1365-2249.2010.04143.x
|
[19]
|
Neumann, J. (1890) über das Vorkommen der sogenannten “Mastzellen” bei pathologishen Veranderung des Gehirns. Virchows Archiv, 122, 378-380.
https://doi.org/10.1007/BF01884453
|
[20]
|
Olsson, Y. (1974) Mast Cells in Plaques of Multiple Sclerosis. Acta Neurologica Scandinavica, 50, 611-618. https://doi.org/10.1111/j.1600-0404.1974.tb02806.x
|
[21]
|
Thoms, R., Weiner, H.L. and Johnson, D. (1990) Identification of IgE-Positive Cells and Mast Cells in Frozen Sections of Multiple Sclerosis Brains. Neuroimmunology, 30, 167-177. https://doi.org/10.1016/0165-5728(90)90101-R
|
[22]
|
Theoharides, T.C. (1990) Mast Cells: The Immune Gate to the Brain. Life Sciences, 46, 607-617. https://doi.org/10.1016/0024-3205(90)90129-F
|
[23]
|
Krüger, P.G., Bo, L., Myhr, K.-M., Karlsen, A.E., Taule, A., Nyland, H. and Mork, S. (1990) Mast Cells and Multiple Sclerosis: A Light and Electro Microscopic Study of Mast Cells in Multiple Sclerosis Emphasizing Staining Procedures. Acta Neurologica Scandinavica, 81, 31-36.
https://doi.org/10.1111/j.1600-0404.1990.tb00927.x
|
[24]
|
Ibrahim, M.Z.M., Reder, A.T., Lawand, R., Taksh, W. and Sallouh-Khatib, S. (1996) The Mast Cells of the Multiple Sclerosis Brain. Journal of Neuroimmunology, 70, 131-138. https://doi.org/10.1016/S0165-5728(96)00102-6
|
[25]
|
Krüger, P.G. (2001) Mast Cells and Multiple Sclerosis: A Quantitative Analysis. Neuropathology and Applied Neurobiology, 27, 275-280.
https://doi.org/10.1046/j.0305-1846.2001.00331.x
|
[26]
|
Krüger, P.G. and Mork, S. (2012) Mast Cells and Multiple Sclerosis in Females and Males. World Journal of Neuroscience, 2, 145-149.
https://doi.org/10.4236/wjns.2012.23022
|
[27]
|
Rozniecki, J.J., Hauser, S.L., Stein, M., Lincoln, R. and Theoharides, T.C. (1995) Elevated Mast Cell Tryptase in Cerebrospinal Fluid of Multiple Sclerosis Patients. Annals of Neurology, 37, 63-66. https://doi.org/10.1002/ana.410370112
|
[28]
|
Dropp, J.J. (1979) Mast Cells in the Human Brain. Acta Anatomica, 105, 505-513.
https://doi.org/10.1159/000145157
|
[29]
|
Orton, S.M., Herrera, B.M., Yee, I.M., Valdar, W., Ramagopalan, S.V., Sadovnick, A.D. and Ebers, G.C. (2006) Sex Ratio of Multiple Sclerosis in Canada, a Longitudinal Study. The Lancet Neurology, 5, 932-936.
https://doi.org/10.1016/S1474-4422(06)70581-6
|
[30]
|
Johnson, D., Seeldrayers, P.A. and Weiner, H.L. (1988) The Role of Mast Cells in Demyelination. I Myelin Proteins Are Degraded by Mast Cell Proteases and Myelin Basic Protein and P2 Can Stimulate Mast Cell Degranulation. Brain Research, 444, 195-198. https://doi.org/10.1016/0006-8993(88)90929-8
|
[31]
|
Krüger, P.G. and Lagunoff, D. (1981) Mast Cell Restoration. A Study of the Rat Peritoneal Mast Cells after Depletion with Polymyxin B. International Archives of Allergy and Immunology, 65, 278-290. https://doi.org/10.1159/000232767
|
[32]
|
Hammel, I., Lagunoff, D. and Krüger, P.G. (1989) Recovery of Rat Mast Cells after Secretion: A Morphometric Study. Experimental Cell Research, 184, 518-523.
https://doi.org/10.1016/0014-4827(89)90349-2
|
[33]
|
Krüger, P.G. (2014) Mast Cells: The Key to Multiple Sclerosis? World Journal of Neuroscience, 4, 120-124. https://doi.org/10.4236/wjns.2014.42014
|
[34]
|
Galli, S.J., Borregaard, N. and Wynn, T.A. (2011) Phenotypic and Functional Plasticity of Cells of Innate Immunity: Macrophages, Mast Cells and Neutrophils. Nature Immunology, 12, 1035-1044. https://doi.org/10.1038/ni.2109
|
[35]
|
Czarnetzki, B.M., Krüger, G. and Sterry, W. (1983) In Vitro Generation of Mast Cell-Like Cells from Human Peripheral Mononuclear Phagocytes. International Archives of Allergy and Immunology, 71, 161-167.
https://doi.org/10.1159/000233381
|
[36]
|
Kambayashi, C., Allenspach, E.J., Chang, J.T., Zou, T., Shang, J., Reiner, S.L., Caton, A.J. and Kretzky, G.A. (2009) Inducible HMC Class II Expression by Mast Cells Supports Effector and Regulatory T Cell Activation. The Journal of Immunology, 182, 4686-4695. https://doi.org/10.4049/jimmunol.0803180
|
[37]
|
Krüger, P.G. and Nyfors, A. (1984) Phagocytosis by Mast Cells in Urticaria Pigmentosa. Acta Dermato-Venereologica, 64, 373-377.
|
[38]
|
Theoharides, T.C., Alysandratos, K.-D., Angelidou, A., Delivanis, D.-A., Sismanopoulos, N., Zhang, B., Asadi, S., Vasiadi, M., Weng, Z., Minati, A. and Kalogeromitros, D. (2012) Mast Cells and Inflammation. Biochimica et Biophysica Acta, 1822, 21-33. https://doi.org/10.1016/j.bbadis.2010.12.014
|
[39]
|
Esposito, P., Chandler, N., Kandere K., Basu, S., Jacobson, S., Connolly, R., Tutor, D. and Theoharides, T.C. (2002) Corticotropin-Releasing Hormone and Brain Mast Cells Regulate Blood-Brain-Barrier Permeability Induced by Acute Stress. Journal of Pharmacology and Experimental Therapeutics, 303, 1061-1066.
https://doi.org/10.1124/jpet.102.038497
|
[40]
|
Theoharides, T.C. and Cochrane, D.E. (2004) Critical Role of Mast Cells in Inflammatory Diseases and the Effect of Acute Stress. Journal of Neuroimmunology, 146, 1-12.
|
[41]
|
Ackerman, K.D., Heyman, R., Rabin, B.S., Anderson, B.P., Houck, P.R., Frank, E. and Baum, A. (2002) Stressful Life Events Precede Exacerbations of Multiple Sclerosis. Psychosomatic Medicine, 64, 916-920.
|
[42]
|
Artemiadis, A.K., Anognostouli, M.C. and Alexopoulos, E.C. (2011) Stress as a Risk Factor for Multiple Sclerosis Onset or Relapse: A Systematic Review. Neuroepidemiology, 36, 109-120. https://doi.org/10.1159/000323953
|
[43]
|
Krüger, P.G., Mahata, S.K. and Helle, K.B. (2002) Catestatin (Chromogranin A344-358) Stimulates Release of Histamine from Rat Pleural and Peritoneal Mast Cells. Annals of the New York Academy of Sciences, 971, 349-351.
https://doi.org/10.1111/j.1749-6632.2002.tb04493.x
|
[44]
|
Moran-Ramos, S., Tovar, A.R. and Torres, N. (2012) Diet: Friend or Foe of Enteroendocrine Cells: How It Interacts with Enteroendocrine Cells. Advances in Nutrition, 3, 8-20. https://doi.org/10.3945/an.111.000976
|